Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

  • This share is currently suspended. It was suspended at a price of 0.112
  • There is currently no data for SCE

Pre Close Trading Statement

16 Jun 2011 07:00

RNS Number : 5183I
Surface Transforms PLC
16 June 2011
 

Surface Transforms Plc ("Surface Transforms" or the "Company")

 

PRE CLOSE TRADING STATEMENT

Surface Transforms, one of the world's two manufacturers of ceramic brake discs for the aircraft and automotive industries, is pleased to provide a trading update for the financial year ending 31 May 2011.

 

The Company's turnover is expected to be in excess of £860,000, some 7% higher than last year (2010: £804,800). Nevertheless, turnover was less than originally budgeted, principally due to delays in securing new automotive brake contracts.

 

We reported in the interim statement that the Company's pre-tax losses for the year are likely to be materially higher than last year due to higher development costs and much lower R&D tax credit receipts. The Board has already taken steps to reduce the Company's cost base from June 2011 and the reduction in overheads of approx £170,000 p.a., together with ongoing improvements to product costs, aim to reduce the turnover levels at which the Company can break even in cash terms.

 

The order book and contracted sales for the year ending 31 May 2012 currently total £568,000 (31 May 2010: £521,996). The contracted sales, expected to be in excess of £280,000 relate to a three year, forward contractual supply agreement the Company entered into in March 2011 with one of its main clients, Mov'IT International. This contract expires on 31 December 2014. The agreement provides for the sale of ceramic brake discs and has a minimum value of approximately £2.7 million (€3.1 million) over the term.

 

Management focus in the current year is to deliver improved operating margins on its improving sales to the current customer base and hence drive the business towards cash break-even levels. The Board expects an improvement in the Company's performance over the next 12 months and will update shareholders further when the audited accounts are published.

 

For further information on the Company visit: www.surface-transforms.com

 

Kevin D'Silva

Chairman

 

Enquires:

Dr Kevin Johnson, CEO 0151 356 2141

Geoff Hall, Co. Secretary & Finance Controller 0151 356 2141

 

Seymour Pierce Ltd 0207 107 8000

Guy Peters/David Foreman - Corporate Finance

Paul Jewell/David Banks - Corporate Broking

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEELFFFQFZBBL
Date   Source Headline
13th Nov 20234:56 pmRNSProposed Placing, Subscription and Open Offer
3rd Nov 20237:05 amRNSTrading Update
16th Oct 20237:00 amRNS£100m New Business Award from OEM 10
28th Sep 20231:55 pmEQSHardman & Co Research on Surface Transforms (SCE): Interim results
27th Sep 20237:00 amRNSInterim results for six months ended 30 June 2023
31st Jul 20237:00 amRNSPre-close trading update and operations update
20th Jul 20237:00 amRNSDirector Dealing
5th Jul 20237:00 amRNSHolding(s) in Company
27th Jun 20235:02 pmRNSResult of Annual General Meeting
27th Jun 20237:00 amRNSAGM Statement
26th Jun 20234:55 pmRNSExercise of Options and Total Voting Rights
21st Jun 20237:00 amRNSAward of LSE Green Economy Mark
20th Jun 202311:38 amRNSPDMR Dealing
19th Jun 20237:00 amRNSAppointment of new Chief Finance Officer
2nd Jun 20237:00 amRNSExercise of Options and Total Voting Rights
31st May 202312:51 pmRNSPosting of Annual Report and Notice of AGM
30th May 20237:00 amRNSAppointment of new Chief Operating Officer
23rd May 20237:00 amRNSExercise of Options and Total Voting Rights
18th May 20231:30 pmEQSHardman & Co Q&A on Surface Transforms (SCE): Production ramp up secured in a potential £2bn a year market
9th May 20237:30 amEQSHardman & Co Research on Surface Transforms (SCE): A major quantum production ramp up now secured
5th May 20237:00 amRNSDirector Dealing
27th Apr 202312:35 pmEQSHardman & Co Video | Surface Transforms (SCE) Presentation and Q&A with the Board
24th Apr 20237:00 amRNSHolding(s) in Company
24th Apr 20237:00 amRNSDirector dealing and total voting rights
17th Apr 20237:00 amRNSPreliminary Results and Notice of AGM
6th Apr 202312:45 pmEQSHardman Talks Video Event | Surface Transforms Management Presentation and Q&A
3rd Apr 20237:00 amRNSProduction, Capacity and Trading Update
27th Jan 20232:34 pmRNSHolding(s) in Company
11th Jan 20237:00 amRNSTrading and operations update
20th Dec 20227:00 amRNSDirectorate Change
19th Dec 20227:00 amRNSPDMR Share Dealing & Total Voting Rights
15th Dec 202210:22 amEQSHardman & Co Research : Surface Transforms (SCE): Major OEM 10 order, OEM 8 delay resolved
24th Nov 20227:00 amRNSOEM 10 Contract Award and Trading Update
9th Nov 20224:42 pmRNSExercise of Options
27th Oct 202211:05 amRNSHolding(s) in Company
24th Oct 202211:15 amRNSHolding(s) in Company
20th Oct 20228:01 amRNSDirector Dealing
19th Oct 202212:23 pmRNSResult of General Meeting & Total Voting Rights
19th Oct 20227:00 amRNSResult of Open Offer
6th Oct 20222:20 pmEQSHardman & Co Research on Surface Transforms (SCE): The large growth is now self-financing
6th Oct 202212:05 pmEQSHardman & Co: Hardman Talks Video | Surface Transforms Surface Transforms presentation and Q&A with the Board
30th Sep 202211:02 amRNSInvestor Presentation
29th Sep 20221:25 pmEQSHardman & Co Research : Hardman Talks Video Event | Surface Transforms Management Presentation and Q&A
29th Sep 20228:33 amRNSResult of Placing, Open Offer Launch & GM Notice
28th Sep 20225:03 pmRNSProposed Placing, Subscription and Open Offer
12th Sep 202212:00 pmEQSHardman & Co Q&A on Surface Transforms (SCE): It's all in the detail
6th Sep 20227:15 amEQSHardman & Co Research on Surface Transforms (SCE): Further new order, upgrades, production ramp-up
5th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSContract award from OEM 9
19th Aug 20227:00 amRNSRetirement of non-executive director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.